To carry out their activities, Research Teams of the Frédéric Joliot Institute for Life Sciences have developed high-profile technological platforms in many areas : biomedical imaging, structural biology, metabolomics, High-Throughput screening, level 3 microbiological safety laboratory...
Within the Institute, the "Funding Research and Technology Transfer" team is at your disposal to identify the scientists and the skills you need to set up a joint project, to define the terms of a collaboration contract or study.
Whether you are an academic, a SME or an industrialist, our team informs and advices you about the possibilities of consortium assembly, technology transfer, patent licensing or use of our platforms.
The team is also at the disposal of the researchers of the institute to accompany them in achieving their valorization objectives.
All the news of the Institute of life sciences Frédéric Joliot
Laboratory | Stress response
The LSOD includes researchers characterizing the molecular mechanisms of stress-related proteins (hemoproteins, flavoproteins and metalloproteins) or detoxification (cytochromes P450, glutathione S-transferase, P-glycoprotein), using biochemical, enzymological, biophysical and bioinformatics techniques.
Oxidative stress is an essential phenomenon to the initiation and development of many diseases including cancer, inflammatory diseases, cardiovascular and neurodegenerative diseases. However, the mechanisms of detoxification and production of reactive oxygen and nitrogen species (RNOS see Figure) and their biological reactivity are not yet characterized in a clear and complete fashion. This is illustrated in the case of neurodegenerative diseases for which the presence and activity of detoxification enzymes have been described only recently and partially. RNOS seem to play different if not opposite roles, such as signalling, neuroprotection or cytotoxicity. Our team strives to decipher the catalytic processes of detoxification or production of RNOS, with special attention to several systems strongly implicated in these diseases :
To fight against aggressions by xenobiotics, the human body has developed three specialized and complementary enzyme systems for the elimination of foreign compounds and which are involved in cellular detoxification (see Figure). These enzymes are cytochromes P450 (CYPs) in the phase functionalization (Phase I metabolism of xenobiotics), conjugation enzymes so-called transferases (phase II) such as the glucuro- or glutathione-S-transferases (including membrane mGST1), and transport proteins such as efflux and P-glycoprotein (P-gp) (Phase III). They are localized in different membranes (endoplasmic reticulum or plasma membrane) and can act synergistically to produce efficient detoxifications of the liver, the principal organ exposed to xenobiotics by the oral route. CYP3A4 and P-gp are characterized by a multispecific molecular recognition towards a great variety of chemical structures and share many common substrates. Because of their hydrophobicity, these common substrates are recognized by these enzymes within the membrane.
We are interested in understanding the functional synergy of the undertaking by mGST1 or P-gp of metabolites produced by P450s, particularly CYP3A4, and in determining the molecular mechanisms of multispecies recognition of these three membrane proteins. These enzymes are thus able to operate "in parallel" to protect the cell against hydrophobic toxic species but also "in series", that is, a product of the enzymatic activity of CYP3A4 could be transported out of the cell by P-gp or via mGST1. The investigated molecules are in particular drugs in development and compounds found in our environment and that can lead to health problems.
At a molecular level, we study the structure-function relationships of a number of proteins that play an important role in oxidative stress and cellular detoxification. To better understand the catalytic mechanisms and the intramolecular electron (and possibly proton) transfer at the origin of the functional properties of these proteins, we aim in particular at determining the structure and environment heme of active sites (NOS, NOS-like proteins, cytochromes P450, oxygen carriers, amyloid β-heme complex), non-heme centers (metal-peptide complexes, superoxide reductase) and flavin (flavoproteins belonging to the pyridine nucleotide-disulfide oxidoreductases family , NOS reductase domain).
A wide range of methodologies is implemented. It includes enzymology, molecular biology, rapid kinetics measurements, biomimetic chemistry, vibrational spectroscopies (IR and Raman), electronic absorption and electron spin resonance (conventional and pulsed EPR, ENDOR), and bioinformatics (molecular dynamics, docking).
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.